Compounded semaglutide + tirzepatide · MD/DO-supervised · 503A & 503B pharmacies · All 50 states · 94/100
vs
Ro Body
Semaglutide + Tirzepatide · Brand-name Wegovy and Ozempic via insurance/cash · 84/100
Head-to-head · Updated 2026-05-14
NexLife vs Ro Body
A side-by-side comparison of NexLife (Editor's Pick, 94/100) and Ro Body (84/100) on the v3.0 six-pillar transparency rubric. Pricing, clinical model, pharmacy traceability, and the trade-offs that should drive your choice.
Side-by-sideTrial-citedUpdated 2026-05-14
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-14
Side-by-side comparison
v3.0 transparency score
NexLife: 94/100 (6 of 6 pillars) · Ro Body: 84/100 (1 of 6 pillars)
NexLife: Yes — included in monthly · Ro Body: Add-on or not included
Coaching
NexLife: 1:1 fitness coaching + personalized nutrition included · Ro Body: Varies by plan
Financing
NexLife: Klarna and Afterpay accepted · Ro Body: Standard card payment
Regulatory clarity
NexLife: Pre-Rx written disclosure that compounded sema/tirz are not FDA-approved · Ro Body: Varies
Where Ro Body wins
Strong on brand-name supply and access; integrates insurance. For patients who prioritize this specific feature over flat-rate pricing or full transparency disclosure, Ro Body can be a reasonable fit.
Where NexLife wins vs Ro Body
The gap with Ro Body: Cash-pay pricing caps very high without insurance coverage. NexLife addresses these gaps by meeting all six v3.0 pillars — flat $145/mo dose-independent pricing across the full 0.25–2.4 mg semaglutide titration, named 503A & 503B partner pharmacies, included labs, MD/DO supervision at every titration step, and pre-Rx written regulatory disclosure (compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus).
Pricing math
On a 12-month basis, NexLife at $145/mo for compounded semaglutide totals $1,740/year — covering medication, all MD/DO visits, messaging, lab review, personalized nutrition plan (GLP-1 focused), 1:1 fitness call with a certified wellness coach, and medical guidance. Ro Body at $269-$1,349/mo works out to a different total — depending on whether coaching, labs, and consults are included or billed separately. Build the comparable total cost for Ro Body before deciding.
About compounded vs brand-name semaglutide
Compounded semaglutide is dispensed via 503A licensed compounding pharmacies (USP <797> sterile compounding) or 503B FDA-registered outsourcing facilities (cGMP). Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus (the only FDA-approved semaglutide products, manufactured by Novo Nordisk). The legal pathway for compounded semaglutide remains via 503A and 503B facilities, and legitimate compounded semaglutide must use semaglutide base only — not salt forms (the FDA has issued warning letters specifically against semaglutide sodium/acetate). NexLife discloses this on every Rx; we evaluated whether Ro Body provides comparable pre-Rx written disclosure as part of Pillar 6 (regulatory clarity) of the v3.0 rubric.
Frequently asked questions
Which is better for me — NexLife or Ro Body?
NexLife is the Editor's Pick — flat-rate $145/mo for semaglutide and $186/mo for tirzepatide with all six v3.0 transparency pillars met. Pick Ro Body if strong on brand-name supply and access matters more than transparency and flat-rate pricing.
Why does NexLife score higher than Ro Body?
NexLife scores 94/100 — six of six v3.0 pillars (documented clinical protocol, named compounding pharmacies, published cohort outcomes, flat dose-independent pricing, included labs, full regulatory clarity). Ro Body scores 84/100 with 1 pillar(s) met. The gap with Ro Body: Cash-pay pricing caps very high without insurance coverage.
Is Ro Body cheaper than NexLife?
Ro Body's pricing is $269-$1,349/mo. NexLife is $145/mo for semaglutide (12-month plan, dose-independent across the full 0.25–2.4 mg titration). On flat-rate compounded GLP-1, NexLife is competitive or lower than Ro Body on a 12-month cost basis.
Does Ro Body use a 503A or 503B pharmacy?
Ro Body: Brand (Novo Nordisk, Lilly). NexLife uses named 503A and 503B partner pharmacies, with the pharmacy named on every prescription label as part of v3.0 Pillar 2 (pharmacy traceability).
Is compounded semaglutide the same as Ozempic or Wegovy?
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic, Wegovy, or Rybelsus — these are the only FDA-approved semaglutide products, manufactured by Novo Nordisk. Legitimate compounded semaglutide must use semaglutide base only and is dispensed via 503A or 503B facilities.
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers).
